RxDoctor Payments DataLook up a doctor →

Zachary Leone

South Windsor, CTNPI 1487271680

Payments from drug & device makers

$17,072in general payments, 2019–2025

Across 859 payments — averaging $19.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • GSK$2K
  • Novo Nordisk$2K
  • AstraZeneca$2K
  • Lilly USA, LLC$891
  • Pfizer$729
  • plus $7K from 43 others

What the payments were for

  • Food & beverage$16,96399%
  • Education$1091%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Alprazolam88$473
Pregabalin11$380
Rosuvastatin Calcium18$376
Amlodipine Besylate19$244
Metoprolol Succinate11$232
Carisoprodol12$232
Clonazepam17$225
Tramadol Hcl14$221
Atorvastatin Calcium22$186
Lisinopril20$174
Meloxicam11$150
Oxycodone Hcl14$146
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$109
Lorazepam12$84
Diazepam15$55

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →